Ionis Pharmaceuticals News

J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $51

Moomoo News07:31 ET · Ratings

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and GoodRx Holdings (GDRX)

TipRanks07:10 ET · Ratings

Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks 11:15 ET

Praxis Precision Medicines to Showcase Updates From Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

GlobeNewswireNov 26 08:00 ET

Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby

Seeking AlphaNov 23 08:26 ET

Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now

Yahoo FinanceNov 19 19:08 ET

Here's Why Ionis Pharmaceuticals (IONS) Is Poised for a Turnaround After Losing -13.46% in 4 Weeks

Zacks Nov 18 08:50 ET

Express News | Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS

BenzingaNov 15 15:21 ET

Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event

Seeking AlphaNov 15 15:00 ET

Ionis Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow JonesNov 14 09:26 ET · Ratings

Flamingo Therapeutics Announces Oral Presentation at AACR Special Conference in Cancer Research on RNAs as Drivers, Targets, and Therapeutics in Cancer

PR NewswireNov 14 08:00 ET

Piper Sandler Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $62

Moomoo NewsNov 14 07:31 ET · Ratings

10 Health Care Stocks Whale Activity In Today's Session

BenzingaNov 12 12:35 ET

Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Shares Lagging The Industry But So Is The Business

Simply Wall StNov 9 07:07 ET

A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $45 to $77

Moomoo NewsNov 8 08:00 ET · Ratings

Ionis Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceNov 8 05:46 ET

Ionis Pharmaceuticals: Promising Pipeline and Strategic Milestones Drive Buy Rating

TipRanksNov 8 02:27 ET · Ratings

Where Ionis Pharmaceuticals Stands With Analysts

BenzingaNov 7 08:01 ET

A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $51 to $77

Moomoo NewsNov 7 08:00 ET · Ratings

Ionis to Present at Upcoming Investor Conferences

PR NewswireNov 7 07:05 ET